Global Transcatheter Devices Market

Global Transcatheter Devices Market Size, Share, Growth Analysis, By Product(Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices), By Application(Cardiovascular, Oncology) - Industry Forecast 2024-2031

Report ID: SQMIG35A2584 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 65 | Figures: 75

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Transcatheter Devices Market size was valued at USD 12.32 billion in 2022 and is poised to grow from USD 13.99 billion in 2023 to USD 38.66 billion by 2031, growing at a CAGR of 13.55% in the forecast period (2024- 2031).

The competitive landscape of the global transcatheter devices market is marked by a dynamic interplay of established medical device manufacturers and innovative startups. Companies within this landscape strive to leverage cutting-edge technology to develop minimally invasive solutions that address various medical conditions across applications such as cardiovascular, oncology, neurology, and urology. The pursuit of enhanced patient outcomes reduced procedural complexities, and shorter recovery times has fueled intense competition. 'CryoLife, Inc. (US)', 'Edwards Lifesciences Corporation (US)', 'Abbott (US)', 'Boston Scientific Corporation (US)', 'enaValve Technology, Inc. (US)', 'Terumo Corporation (Japan)', 'Neovasc Inc. (Canada)', 'Meril Life Sciences Pvt. Ltd. (India)', 'Symetis SA (Switzerland)', 'Venus Medtech (Hangzhou) Inc. (China)', 'Medtronic plc (Ireland)', 'W.L. Gore & Associates (US)', 'JenaValve Technology, Inc. (US)', 'Xeltis AG (Switzerland)', 'LivaNova PLC (UK)', 'Endologix Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Biosensors International Group, Ltd. (Singapore)', 'Direct Flow Medical, Inc. (US)', 'Transcatheter Technologies GmbH (Germany)'

As medical technology evolves, there is a growing emphasis on procedures that reduce patient discomfort, hospital stays, and recovery times. Transcatheter devices, such as stents, valves, and embolization devices, play a crucial role in enabling minimally invasive interventions across various medical specialties. These devices allow medical professionals to access targeted areas within the body through small incisions, reducing the need for traditional open surgeries. As patient preferences shift towards procedures that offer quicker recovery and fewer complications, the adoption of transcatheter devices is on the rise, driving innovation and reshaping treatment approaches in the healthcare industry.

Increasing Adoption of Transcatheter Aortic Valve Replacement (TAVR) Procedures: TAVR has gained significant momentum as a minimally invasive alternative to traditional open-heart surgery for treating aortic valve diseases, especially in elderly patients and those at high surgical risk. This trend is propelled by the procedure's reduced recovery time, shorter hospital stays, and lowered complications, thereby catering to patient preferences for less invasive interventions. The expanding pool of geriatric patients and the advancements in TAVR techniques are driving its increasing application across various regions. Moreover, ongoing research and development efforts are further refining TAVR technologies, broadening their applicability and ensuring improved patient outcomes in the global transcatheter devices market.

North America emerges as the dominating region in the global transcatheter devices market. This prominence is rooted in the region's advanced healthcare infrastructure, substantial investments in medical research and innovation, and high prevalence of chronic diseases such as cardiovascular conditions. The availability of skilled healthcare professionals, favorable reimbursement policies, and a proactive approach towards adopting novel medical technologies contribute to North America's leadership position.

Related Reports

Urometer Market
Buy Now GET FREE SAMPLE
Medical Device Security Market
Buy Now GET FREE SAMPLE
Non-Powered Air Purifying Respirator Market
Buy Now GET FREE SAMPLE
Open MRI Systems Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Transcatheter Devices Market

Product ID: SQMIG35A2584

$5,300
BUY NOW